Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

Colorectal NeoplasmsLiver Neoplasms

Interventions

DRUG

Combination therapy of irinotecan with 5-FU, leucovorin plus bevacizumab in the neoadjuvant setting.

Trial Locations (2)

Pfizer Investigational Site, New York

Pfizer Investigational Site, Philadelphia